Table 6.
Beta-Lactamase Assay Protocol for Trk-NFAT-bla CHO-K1 Cells in 384-Well Format
| Variable | B | S.E. | Wald | df | Sig. | Exp(B) | 95,0% C.I. for EXP(B) | |
| Lower | Upper | |||||||
| Smoker | 0.981 | 0.407 | 5.796 | 1 | 0.016 | 2.667 | 1.200 | 5.925 |
| HDL-C | -0.056 | 0.020 | 7.662 | 1 | 0.006 | 0.946 | 0.909 | 0.984 |
| IL-13 | 6.804 | 2 | 0.033 | |||||
| IL-13(1-RQ) | 0.723 | 0.378 | 3.671 | 1 | 0.055 | 2.061 | 0.984 | 4.320 |
| IL-13(2-QQ) | 1.758 | 0.851 | 4.263 | 1 | 0.039 | 5.799 | 1.093 | 30.754 |
| Constant | 1.237 | 0.924 | 1.792 | 1 | 0.181 | 3.444 | ||
HDL-C = high density lipoprotein cholesterol; IL-13 = interleukin 13.
Variables which are significant contributors to the occurrence of an MI in a sample of Cypriot men (smoking, relatively low HDL-C and the IL-13 R130Q mutation).